For food manufacturing and other large facilities
- Put on proper PPE. This includes goggles and/or face shield, protective clothing, and rubber gloves.
- Treat all surfaces with an alkaline detergent, followed with a water rinse
- Prepare solution of Sterilex Ultra Disinfectant Cleaner Solution 1 and Ultra Soft Metal Activator mixed at a 1:1:8 – 1:1:10 ratio (12.8 – 16 oz of each solution/gallon of water) for use in a high volume, rinsed tank foamer. Use Sterilex product solution within 8 hours of mixing.
- Generously foam all overheads, walls, equipment, floors and drains to ensure thorough coverage. Allow chemistry to soak in all crevices of treated surfaces
- Minimum contact time: 10 minutes
- Recommended Contact Time: 30 minutes
- Water Temperature: 100°F to 140°F
- Rinse all food contact surfaces thoroughly with a potable water rinse.
- Repeat procedure as needed.
Note: For application on hard, non-porous surfaces only. Directions for use are consistent with those for Feline calicivirus. See product label for details.
While most portable spray units will work, we recommend Foam-It equipment. Two options are featured here, but sizes up to 50 gallons are available at www.foamit.com.
While most portable foaming units will work, we recommend Foam-It equipment. The units featured here will provide ease of use, but sizes up to 50 gallons available at www.foamit.com.
For large scale foaming applications. We recommend the EZBlend® Foam Unit, which provides for additional ease of use.
5 gallon mixing buckets are available at most hardware stores, or online via Amazon or Grainger. When selecting a unit, we highly recommend using a graduated bucket that will allow for easy measurement.
The claims made above are a result of the EPA Emerging Viral Pathogen Policy. EPA published guidance in 2016 outlining a pathway for EPA registrants to make claims against emerging viral pathogens that are not included on the EPA-registered label. This policy is intended to provide companies with an avenue to make claims against pathogens of major public health concern that cannot reasonably be added to a product label in a timely manner. Coronavirus (SARS-CoV-2) currently falls under this pathway. In order to make these claims, companies must complete a 2-stage process.
- Have proven efficacy against key viral pathogens and add the designated emerging viral pathogen statement to their master label.
- Agree to abide by the restrictions of the Emerging Viral Pathogen policy, and remove claims once the outbreak has ended.
The current policy lists three viral subgroups, organized in a hierarchy. Demonstrated efficacy against viral pathogens in a higher class would imply efficacy against pathogens in a lower class.
- Small, non-enveloped viruses
- Large, non-enveloped viruses
- Enveloped viruses
Coronavirus (SARS-CoV-2) falls under the enveloped virus category of pathogens. In order for disinfectants to make claims against emerging enveloped viruses, they must have demonstrated efficacy against at least one large or one small non-enveloped virus. Both Sterilex products have demonstrated efficacy against Feline calicivirus — a small, non-enveloped virus — implying efficacy over an enveloped virus such as Coronavirus (SARS-CoV-2).
You can read the full emerging viral pathogen guidance on the EPA Website.